These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22890797)
21. Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A₂ inhibition. Yu JA; Sadaria MR; Meng X; Mitra S; Ao L; Fullerton DA; Weyant MJ J Thorac Cardiovasc Surg; 2012 Feb; 143(2):405-11. PubMed ID: 22248682 [TBL] [Abstract][Full Text] [Related]
22. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo. Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401 [TBL] [Abstract][Full Text] [Related]
23. Expression profile of multiple secretory phospholipase A(2) isoforms in the rat CNS: enriched expression of sPLA(2)-IIA in brainstem and spinal cord. Ma MT; Nevalainen TJ; Yeo JF; Ong WY J Chem Neuroanat; 2010 Jul; 39(4):242-7. PubMed ID: 20153419 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395 [TBL] [Abstract][Full Text] [Related]
25. Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes. Kedar E; Rutkowski Y; Braun E; Emanuel N; Barenholz Y J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):47-59. PubMed ID: 8081559 [TBL] [Abstract][Full Text] [Related]
26. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. Zhang J; Jin W; Wang X; Wang J; Zhang X; Zhang Q Mol Pharm; 2010 Aug; 7(4):1159-68. PubMed ID: 20524673 [TBL] [Abstract][Full Text] [Related]
28. Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test. Foged C; Nielsen HM; Frokjaer S Int J Pharm; 2007 Mar; 331(2):160-6. PubMed ID: 17156952 [TBL] [Abstract][Full Text] [Related]
29. Revisiting the use of sPLA Pourhassan H; Clergeaud G; Hansen AE; Østrem RG; Fliedner FP; Melander F; Nielsen OL; O'Sullivan CK; Kjær A; Andresen TL J Control Release; 2017 Sep; 261():163-173. PubMed ID: 28662900 [TBL] [Abstract][Full Text] [Related]
30. Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo. Li H; Yuan D; Sun M; Ping Q Drug Deliv; 2016 Nov; 23(9):3562-3572. PubMed ID: 27432585 [TBL] [Abstract][Full Text] [Related]
31. Role of secretory phospholipases in atherogenesis. Jönsson-Rylander AC; Lundin S; Rosengren B; Pettersson C; Hurt-Camejo E Curr Atheroscler Rep; 2008 Jun; 10(3):252-9. PubMed ID: 18489854 [TBL] [Abstract][Full Text] [Related]
32. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer. Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961 [No Abstract] [Full Text] [Related]
33. Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo. Huang Y; Chen XM; Zhao BX; Ke XY; Zhao BJ; Zhao X; Wang Y; Zhang X; Zhang Q AAPS PharmSciTech; 2010 Jun; 11(2):752-9. PubMed ID: 20443090 [TBL] [Abstract][Full Text] [Related]
34. Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury. Titsworth WL; Liu NK; Xu XM CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):254-69. PubMed ID: 18673210 [TBL] [Abstract][Full Text] [Related]
35. Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice. Hagtvet E; Evjen TJ; Olsen DR; Fossheim SL; Nilssen EA J Drug Target; 2011 Sep; 19(8):701-8. PubMed ID: 21524240 [TBL] [Abstract][Full Text] [Related]
36. Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan. Iwanicki JL; Lu KW; Taeusch HW Exp Lung Res; 2010 Apr; 36(3):167-74. PubMed ID: 20334607 [TBL] [Abstract][Full Text] [Related]
37. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion. Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713 [TBL] [Abstract][Full Text] [Related]